AJG

Shares of Arthur J. Gallagher & Co. Are Plummeting - Will This Trend Continue?

This evening we watched Arthur J. Gallagher & Co. drop -7.4% to a price of $227.04 per share. The large-cap Specialty Insurance company is now trading -11.34% below its average target price of $256.07. Analysts have set target prices ranging from $187.0 to $290.0 per share for Arthur J. Gallagher & Co., and have given the stock an average rating of buy.

The stock has a very low short interest at 1.3%, and a short ratio of 2.92. The company's insiders own 0.93% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 87.5% of Arthur J. Gallagher & Co.'s shares being owned by this investor type.

Institutions Invested in Arthur J. Gallagher & Co.

Date Reported Holder Percentage Shares Value
2023-09-30 Vanguard Group Inc 12% 25,516,130 $5,793,181,983
2023-09-30 Blackrock Inc. 8% 17,020,760 $3,864,393,236
2023-09-30 FMR, LLC 4% 9,664,117 $2,194,141,058
2023-09-30 Capital International Investors 4% 9,651,212 $2,191,211,107
2023-09-30 State Street Corporation 4% 8,699,027 $1,975,027,031
2022-12-31 Norges Bank Investment Management 4% 7,594,081 $1,724,160,099
2023-09-30 Morgan Stanley 3% 6,209,557 $1,409,817,779
2023-09-30 Massachusetts Financial Services Co. 2% 5,396,350 $1,225,187,267
2023-09-30 JP Morgan Chase & Company 2% 5,000,975 $1,135,421,330
2023-09-30 Geode Capital Management, LLC 2% 4,881,758 $1,108,354,303

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Arthur J. Gallagher & Co..

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS